Search Results 151-160 of 16627 for primary sclerosing cholangitis
Mayo researchers were among the first to identify nonalcoholic fatty liver disease and primary sclerosing cholangitis. Mayo researchers are also making ...
About this study. The purpose of this study is to evaluate the safety and effectiveness of seladelpar in subjects with primary biliary cholangitis (PBC) and ...
... primary sclerosing cholangitis mediated chronic liver disease. The most common indications for a BE anastomosis were primary sclerosing cholangitis and duct ...
Mayo researchers were among the first to identify nonalcoholic fatty liver disease and primary sclerosing cholangitis. Mayo researchers also are making ...
... primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC), the latter of which has no medical cure. In 2011, he joined the Mayo Clinic ...
Primary sclerosing cholangitis is a chronic inflammation of the bile ducts ... This study will assist in determining the safety and tolerability of Tarceva in ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.